logo
Select company
Select metric
$ 216.35MWorking Capital
VS
Market
65
Sector
68
Industry
71
History
100
$ 10.18Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information

Ticker

CRMD

Company Name

CORMEDIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CORMEDIX INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRMD - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 248.06M$ 31.71M$ 216.35M
3/31/2025$ 144.86M$ 34.39M$ 110.47M
12/31/2024$ 114.58M$ 33.84M$ 80.74M
9/30/2024$ 73.15M$ 18.48M$ 54.67M
6/30/2024$ 53.19M$ 11.11M$ 42.08M
3/31/2024$ 63.41M$ 9.53M$ 53.88M
12/31/2023$ 79.45M$ 11.4M$ 68.05M
9/30/2023$ 89.06M$ 7.67M$ 81.39M
6/30/2023$ 54.62M$ 7.39M$ 47.24M
3/31/2023$ 56.78M$ 4.67M$ 52.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CORMEDIX INC's latest trailing twelve months (TTM) Working Capital stands at $ 34.26M.
  • Over the past 5 years, CORMEDIX INC's average Working Capital has been $ 69.84M.
  • The median Working Capital for CORMEDIX INC during this period was $ 59.15M
  • CORMEDIX INC reached its highest Working Capital over the past 5 years at $ 216.35M.
  • The lowest Working Capital recorded by CORMEDIX INC in the same timeframe $ 34.26M

CORMEDIX INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
NAGE : NIAGEN BIOSCIENCE INC $ 64.35MZYME : ZYMEWORKS INC $ 257.63MANAB : ANAPTYSBIO INC $ 256.38MPHAT : PHATHOM PHARMACEUTICALS INC $ 127.05MURGN : UROGEN PHARMA LTD $ 149.32MGYRE : GYRE THERAPEUTICS INC $ 74.36MNRIX : NURIX THERAPEUTICS INC $ 358.25MGERN : GERON CORP $ 441.31MSNDX : SYNDAX PHARMACEUTICALS INC $ 418.69MXNCR : XENCOR INC $ 417.07M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for CORMEDIX INC is calculated as follows: AssetsC [ $ 38.87M ] - LiabilitesC [ $ 4.6M ]
(=) Working Capital [ $ 34.26M ]

CRMD - Working Capital, Last 5 years

$ 34.26M

Minimum

Sep 30, 2020

$ 216.35M

Maximum

Jun 30, 2025

$ 69.84M

Average

$ 59.15M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.42M with a standard deviation of $ 173.65M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -457.39M
max$ 607.04M
average$ 96.42M
median$ 32.11M
std$ 173.65M